David Scadden - Jun 1, 2023 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Director
Signature
/s/ David Scadden
Stock symbol
EDIT
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 04:30 PM
Previous filing
Jun 30, 2022
Next filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +25K $0.00 25K Jun 1, 2023 Common Stock 25K $9.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024.